Fluorouracil 50mg/ml Inj20ml

Manufacturer FRESENIUS KABI Active Ingredient Fluorouracil (Systemic)(flure oh YOOR a sil) Pronunciation flure oh YOOR a sil
It is used to treat cancer.
🏷️
Drug Class
Antineoplastic agent
🧬
Pharmacologic Class
Antimetabolite, Pyrimidine analog
🤰
Pregnancy Category
Category D
FDA Approved
Aug 1962
⚖️
DEA Schedule
Not Controlled

Overview

ℹ️

What is this medicine?

Fluorouracil is a chemotherapy drug used to treat various types of cancer. It works by interfering with the growth of cancer cells, which are rapidly dividing cells in your body. Because it affects rapidly dividing cells, it can also affect healthy cells, leading to side effects.
📋

How to Use This Medicine

Taking Your Medication

To use this medication correctly, follow your doctor's instructions and read all the information provided. It's essential to follow the instructions carefully. This medication is administered as an intravenous injection, either as a single dose or continuously over a period of time.

Storing and Disposing of Your Medication

If you need to store this medication at home, consult with your doctor, nurse, or pharmacist for guidance on proper storage.

Missing a Dose

If you miss a dose, contact your doctor to determine the best course of action.
💡

Lifestyle & Tips

  • Maintain good hydration by drinking plenty of fluids.
  • Practice good oral hygiene to prevent mouth sores (mucositis). Use a soft toothbrush and rinse your mouth frequently with a baking soda/salt solution.
  • Avoid spicy, acidic, or rough foods if you develop mouth sores or diarrhea.
  • Protect your hands and feet from friction and pressure to help prevent hand-foot syndrome. Wear comfortable shoes and avoid prolonged standing or walking.
  • Avoid sun exposure and use sunscreen, as fluorouracil can increase sun sensitivity.
  • Report any signs of infection (fever, chills, sore throat) immediately.
  • Avoid contact with people who are sick or have infections.
  • Do not receive any vaccinations without consulting your doctor.
  • Use effective contraception during treatment and for a period after treatment, as advised by your doctor.

Dosing & Administration

👨‍⚕️

Adult Dosing

Standard Dose: Highly variable based on regimen and indication. Common regimens include: 400-500 mg/m² IV bolus weekly or 200-300 mg/m²/day continuous IV infusion for 4-5 days, repeated every 3-4 weeks. Often combined with leucovorin.
Dose Range: 200 - 500 mg

Condition-Specific Dosing:

colorectal_cancer_bolus: 425 mg/m² IV bolus on days 1-5, with leucovorin 20 mg/m² IV bolus, repeated every 4 weeks.
colorectal_cancer_infusion: 200-300 mg/m²/day continuous IV infusion.
breast_cancer: 10-15 mg/kg IV bolus once weekly or 12 mg/kg IV bolus on days 1-5, repeated every 3-4 weeks. Max 800 mg/day.
👶

Pediatric Dosing

Neonatal: Not established
Infant: Not established
Child: Dosing not well-established; used off-label for some pediatric cancers (e.g., CNS tumors, solid tumors). Doses are typically extrapolated from adult regimens or based on specific protocols.
Adolescent: Dosing not well-established; used off-label for some pediatric cancers. Doses are typically extrapolated from adult regimens or based on specific protocols.
⚕️

Dose Adjustments

Renal Impairment:

Mild: No specific dose adjustment recommended, but monitor for toxicity.
Moderate: No specific dose adjustment recommended, but monitor for toxicity. Consider dose reduction if severe toxicity occurs.
Severe: No specific dose adjustment recommended, but monitor for toxicity. Consider dose reduction if severe toxicity occurs.
Dialysis: Fluorouracil is dialyzable. Administer after dialysis. Monitor for increased toxicity.

Hepatic Impairment:

Mild: No specific dose adjustment recommended, but monitor for toxicity.
Moderate: Use with caution. Consider dose reduction (e.g., 30% reduction) in patients with significant hepatic dysfunction (e.g., bilirubin > 5 mg/dL or AST > 4x ULN). Monitor for increased toxicity.
Severe: Use with caution. Consider significant dose reduction (e.g., 50% reduction) or avoidance. Monitor for increased toxicity.

Pharmacology

🔬

Mechanism of Action

Fluorouracil (5-FU) is a fluorinated pyrimidine antimetabolite. It acts as a prodrug that is converted intracellularly to several active metabolites: 5-fluoro-2'-deoxyuridine monophosphate (FdUMP), 5-fluorouridine triphosphate (FUTP), and 5-fluoro-2'-deoxyuridine triphosphate (FdUTP). FdUMP inhibits thymidylate synthase, an enzyme critical for DNA synthesis, leading to 'thymineless death' of rapidly dividing cells. FUTP is incorporated into RNA, interfering with RNA processing and protein synthesis. FdUTP is incorporated into DNA, leading to DNA damage and fragmentation. These actions primarily occur during the S-phase of the cell cycle, making 5-FU cell cycle-specific.
📊

Pharmacokinetics

Absorption:

Bioavailability: Not applicable (IV administration)
Tmax: Not applicable (IV administration)
FoodEffect: Not applicable (IV administration)

Distribution:

Vd: Approximately 0.12 L/kg
ProteinBinding: Low (<10%)
CnssPenetration: Limited (crosses BBB, but concentrations in CSF are lower than in plasma)

Elimination:

HalfLife: Biphasic: Initial phase 10-20 minutes; Terminal phase 6-20 hours (due to prolonged intracellular retention of active metabolites)
Clearance: Highly variable, dependent on DPD activity.
ExcretionRoute: Primarily metabolic degradation (80-90%), with <10% excreted unchanged in urine.
Unchanged: <10%
⏱️

Pharmacodynamics

OnsetOfAction: Rapid (within minutes of IV administration)
PeakEffect: Not directly applicable for cytotoxic effect; cellular effects are cumulative over treatment duration.
DurationOfAction: Dependent on intracellular retention of active metabolites and duration of infusion (can be prolonged for days after infusion).

Safety & Warnings

⚠️

BLACK BOX WARNING

WARNING: FLUOROURACIL SHOULD BE USED ONLY BY OR UNDER THE SUPERVISION OF A QUALIFIED PHYSICIAN EXPERIENCED IN THE USE OF ANTINEOPLASTIC AGENTS. BECAUSE OF THE POSSIBILITY OF SEVERE TOXIC REACTIONS, INCLUDING FATALITIES, THE PATIENT SHOULD BE HOSPITALIZED AT LEAST DURING THE INITIAL COURSE OF TREATMENT. Although severe toxicity is unlikely when fluorouracil is used topically, the potential for serious adverse reactions exists. Dihydropyrimidine dehydrogenase (DPD) deficiency: Patients with partial or complete absence of DPD activity are at increased risk for severe, life-threatening, or fatal toxicity from fluorouracil. Strategies to detect DPD deficiency include genotyping for DPYD variants and phenotyping for DPD activity. Consider testing for DPD deficiency in patients experiencing severe or early-onset toxicity. Discontinue fluorouracil if DPD deficiency is confirmed.
⚠️

Side Effects

Serious Side Effects: Seek Medical Help Right Away

Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor or seek medical attention immediately:

Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of nervous system problems, including:
+ Changes in mood or behavior
+ Confusion
+ Fever
+ Numbness or tingling in the hands or feet
+ Stiff neck
+ Sensitivity to bright lights
+ Severe muscle weakness
Signs of infection, such as:
+ Fever
+ Chills
+ Severe sore throat
+ Ear or sinus pain
+ Cough
+ Increased or changed sputum production
+ Painful urination
+ Mouth sores
+ Wounds that won't heal
Signs of bleeding, including:
+ Vomiting or coughing up blood
+ Vomit that resembles coffee grounds
+ Blood in the urine
+ Black, red, or tarry stools
+ Bleeding gums
+ Abnormal vaginal bleeding
+ Unexplained bruises or bruises that get bigger
+ Uncontrollable bleeding
Feeling extremely tired or weak
Chest pain or pressure
Shortness of breath, significant weight gain, or swelling in the arms or legs
Abnormal heartbeat
Dizziness or fainting
Changes in vision
Redness or irritation on the palms of the hands or soles of the feet
Balance problems
Excessive sleepiness
Uncontrolled eye movements
Headache

Administration Site Reactions

This medication may cause irritation at the injection site. If the medication leaks from the vein, it can also cause irritation around the affected area. Inform your nurse if you experience any redness, burning, pain, swelling, or fluid leakage at the injection site.

Other Side Effects

Like all medications, this drug can cause side effects. Many people may not experience any side effects or may only have mild ones. If you're bothered by any of the following side effects or if they don't go away, contact your doctor or seek medical help:

Diarrhea
Upset stomach or vomiting
Decreased appetite
Mouth irritation or mouth sores
Hair loss
Dry skin
Changes in nail condition

This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, contact your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
🚨

Seek Immediate Medical Attention If You Experience:

  • Fever (especially 100.4°F or higher)
  • Chills
  • Severe diarrhea (more than 4-6 loose stools per day, or bloody diarrhea)
  • Severe mouth sores that make eating or drinking difficult
  • Unusual bleeding or bruising
  • Severe nausea or vomiting that prevents you from keeping food/liquids down
  • Severe pain, redness, swelling, or blistering on hands or feet
  • Chest pain, shortness of breath, or irregular heartbeat
  • Signs of neurological problems: confusion, dizziness, problems with balance or coordination, severe headache, vision changes.
📋

Before Using This Medicine

Before Taking This Medication: Important Information to Share with Your Doctor

It is essential to inform your doctor about the following:

Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Describe the allergic reaction you experienced, including the symptoms that occurred.
Certain health conditions, including:
+ Poor nutrition
+ Active infections
+ Bone marrow problems, such as:
- Low white blood cell count
- Low platelet count
- Low red blood cell count
A genetic condition called dihydropyrimidine dehydrogenase (DPD) deficiency
If you are breast-feeding, as you should not breast-feed while taking this medication

This list is not exhaustive, and it is crucial to discuss all your medications (prescription, over-the-counter, natural products, and vitamins) and health problems with your doctor and pharmacist. They will help determine if it is safe to take this medication with your other medications and health conditions. Never start, stop, or change the dose of any medication without first consulting your doctor.
⚠️

Precautions & Cautions

It is essential to inform all your healthcare providers, including doctors, nurses, pharmacists, and dentists, that you are taking this medication. Regular blood tests and other laboratory evaluations, as directed by your doctor, are crucial to monitor your condition.

This medication can cause low blood cell counts, which may increase the risk of bleeding problems, infections, or anemia. In severe cases, these complications can be life-threatening. If you have any concerns or questions, discuss them with your doctor. Additionally, you may be more susceptible to infections, so it is vital to practice good hygiene by washing your hands frequently and avoiding close contact with people who have infections, colds, or flu.

To minimize the risk of bleeding, be cautious and avoid injuries. Use a soft toothbrush and an electric razor to reduce the risk of bleeding gums or cuts. If you experience stomach upset, vomiting, diarrhea, or loss of appetite, consult your doctor, as there may be ways to alleviate these side effects. It is also crucial to manage diarrhea and vomiting to prevent dehydration and electrolyte imbalances.

Patients who lack the enzyme dihydropyrimidine dehydrogenase (DPD) are at a higher risk of developing severe and potentially life-threatening side effects, including mouth irritation or sores, diarrhea, low white blood cell counts, and nerve problems.

This medication may also increase the risk of heart problems, such as heart attack, heart failure, and abnormal heartbeat, particularly in individuals with a history of heart disease. Discuss your cardiovascular health with your doctor. Before receiving any vaccinations, consult your doctor, as some vaccines may not be effective or may increase the risk of infection when taken with this medication.

You may be more prone to sunburn while taking this medication, so take necessary precautions when exposed to the sun. Inform your doctor if you experience increased sensitivity to sunlight. This medication may also affect fertility, leading to difficulties in becoming pregnant or fathering a child. If you plan to conceive, discuss the potential risks with your doctor before starting treatment.

Women who are pregnant or may become pregnant should not take this medication, as it may harm the unborn baby. If you or your partner may become pregnant, it is essential to use birth control while taking this medication and for a specified period after the last dose. Your doctor will advise you on the duration of birth control use. If you or your partner becomes pregnant, notify your doctor immediately.
🆘

Overdose Information

Overdose Symptoms:

  • Severe myelosuppression (very low white blood cell count, platelet count)
  • Severe mucositis (mouth sores)
  • Severe diarrhea
  • Gastrointestinal hemorrhage
  • Neurotoxicity (ataxia, confusion, seizures)

What to Do:

There is no specific antidote for fluorouracil overdose. Management is supportive, including aggressive hydration, antiemetics, antidiarrheals, antibiotics for neutropenic fever, and blood product transfusions as needed. Uridine triacetate (Vistogard) is an antidote indicated for emergency treatment of fluorouracil or capecitabine overdose or severe, life-threatening or early-onset toxicity in patients with DPD deficiency. Call 1-800-222-1222 (Poison Control).

Drug Interactions

🚫

Contraindicated Interactions

  • Brivudine
  • Sorivudine
🔴

Major Interactions

  • Leucovorin (enhances toxicity)
  • Allopurinol (may decrease 5-FU efficacy)
  • Capecitabine (prodrug of 5-FU, additive toxicity)
  • Cimetidine (may increase 5-FU levels)
  • Metronidazole (may increase 5-FU levels and toxicity)
  • Warfarin (increased INR and bleeding risk)
  • Live vaccines (risk of severe infection)
🟡

Moderate Interactions

  • Phenytoin (may alter phenytoin levels)
  • Thiazide diuretics (may increase myelosuppression)
  • Interferon alfa (may increase 5-FU toxicity)
  • Tamoxifen (may increase 5-FU toxicity)
🟢

Minor Interactions

  • Not specifically documented for minor interactions with significant clinical impact.

Monitoring

🔬

Baseline Monitoring

Complete Blood Count (CBC) with differential

Rationale: To establish baseline hematologic status and assess for pre-existing myelosuppression.

Timing: Prior to initiation of therapy.

Liver Function Tests (LFTs)

Rationale: To assess baseline hepatic function, as 5-FU is primarily metabolized in the liver.

Timing: Prior to initiation of therapy.

Renal Function Tests (RFTs)

Rationale: To assess baseline renal function, although renal excretion of unchanged drug is minimal, severe renal impairment may affect metabolite clearance.

Timing: Prior to initiation of therapy.

DPD deficiency testing (if available/indicated)

Rationale: To identify patients at high risk of severe, life-threatening toxicity due to impaired 5-FU metabolism.

Timing: Consider prior to initiation, especially for high-risk patients or if severe toxicity is anticipated.

📊

Routine Monitoring

Complete Blood Count (CBC) with differential

Frequency: Prior to each dose/cycle and as clinically indicated (e.g., twice weekly during continuous infusion).

Target: Neutrophil count > 1.5 x 10^9/L, Platelet count > 100 x 10^9/L (may vary by protocol).

Action Threshold: Hold or reduce dose for Grade 3/4 myelosuppression (e.g., ANC < 1.0 x 10^9/L, platelets < 50 x 10^9/L).

Liver Function Tests (LFTs)

Frequency: Prior to each cycle or as clinically indicated.

Target: Within normal limits or stable from baseline.

Action Threshold: Hold or reduce dose for Grade 3/4 hepatic toxicity (e.g., bilirubin > 3x ULN, AST/ALT > 5x ULN).

Renal Function Tests (RFTs)

Frequency: Prior to each cycle or as clinically indicated.

Target: Within normal limits or stable from baseline.

Action Threshold: Hold or reduce dose for Grade 3/4 renal toxicity.

Oral Mucosa/GI Assessment

Frequency: Daily during treatment, and regularly between cycles.

Target: Absence of or mild mucositis/diarrhea.

Action Threshold: Hold or reduce dose for Grade 2 or higher mucositis/diarrhea (e.g., inability to eat/drink, severe diarrhea requiring hospitalization).

Skin Assessment (Hand-Foot Syndrome)

Frequency: Regularly during treatment and between cycles.

Target: Absence of or mild skin changes.

Action Threshold: Hold or reduce dose for Grade 2 or higher hand-foot syndrome (e.g., painful erythema, blistering).

👁️

Symptom Monitoring

  • Fever
  • Chills
  • Sore throat
  • Unusual bleeding or bruising
  • Fatigue
  • Weakness
  • Nausea
  • Vomiting
  • Diarrhea (especially severe or bloody)
  • Mouth sores (mucositis)
  • Pain, redness, swelling, or blistering on palms of hands or soles of feet (hand-foot syndrome)
  • Chest pain
  • Shortness of breath
  • Dizziness
  • Confusion
  • Ataxia (loss of coordination)
  • Headache
  • Vision changes

Special Patient Groups

🤰

Pregnancy

Fluorouracil is classified as Pregnancy Category D. It can cause fetal harm when administered to a pregnant woman. It is teratogenic and embryotoxic in animals. Avoid use during pregnancy.

Trimester-Specific Risks:

First Trimester: Highest risk of major congenital malformations and spontaneous abortion.
Second Trimester: Risk of fetal growth restriction, organ toxicity, and other adverse outcomes.
Third Trimester: Risk of fetal growth restriction, myelosuppression, and other adverse outcomes. May affect fetal development and increase risk of premature birth.
🤱

Lactation

Fluorouracil is contraindicated during breastfeeding. It is unknown if fluorouracil is excreted in human milk, but due to the potential for serious adverse reactions in the breastfed infant, breastfeeding should be discontinued during treatment and for a period after the last dose (e.g., 1 week) as advised by the physician.

Infant Risk: High risk of serious adverse effects including myelosuppression, gastrointestinal toxicity, and other cytotoxic effects.
👶

Pediatric Use

Safety and effectiveness in pediatric patients have not been established. Use in pediatric oncology is off-label and based on specific protocols for certain cancers. Dosing requires careful consideration and monitoring due to potential for increased toxicity.

👴

Geriatric Use

Elderly patients may be at increased risk for toxicity (e.g., myelosuppression, mucositis, diarrhea, neurotoxicity) due to decreased organ function or comorbidities. Close monitoring and potential dose adjustments are recommended.

Clinical Information

💎

Clinical Pearls

  • DPD deficiency is a critical consideration; screening should be considered, especially in patients with severe or early-onset toxicity. Uridine triacetate is an antidote for severe toxicity or overdose.
  • Leucovorin is often co-administered with fluorouracil to enhance its cytotoxic effects by stabilizing the binding of FdUMP to thymidylate synthase.
  • Continuous infusion regimens are generally associated with less myelosuppression but more mucositis and hand-foot syndrome compared to bolus regimens.
  • Patients should be educated on the importance of reporting any signs of toxicity promptly, especially fever, severe diarrhea, or mouth sores.
  • Hydration and antiemetic prophylaxis are crucial for managing gastrointestinal toxicities.
🔄

Alternative Therapies

  • Other antimetabolites (e.g., Gemcitabine, Pemetrexed, Methotrexate)
  • Other classes of chemotherapy agents (e.g., platinum compounds, taxanes, topoisomerase inhibitors)
  • Targeted therapies (e.g., EGFR inhibitors, VEGF inhibitors)
  • Immunotherapy (e.g., PD-1/PD-L1 inhibitors)
💰

Cost & Coverage

Average Cost: Varies widely, typically $10-$50 per 500mg vial (generic) per 500mg vial
Generic Available: Yes
Insurance Coverage: Tier 2 or 3 (Specialty drug, often covered under medical benefit for oncology)
📚

General Drug Facts

If your symptoms or health problems do not improve or worsen over time, it is essential to contact your doctor for further guidance. To ensure your safety and the safety of others, never share your prescription medications with anyone, and do not take medications that have been prescribed to someone else.

All medications should be stored in a secure location, out of the reach of children and pets, to prevent accidental ingestion. When disposing of unused or expired medications, do not flush them down the toilet or pour them down the drain unless specifically instructed to do so by a healthcare professional or pharmacist. Instead, consult with your pharmacist to determine the best method for disposal, as some communities may have designated drug take-back programs.

Additionally, some medications may come with a separate patient information leaflet; if you have questions or concerns, consult with your pharmacist. If you have any questions or concerns about your medication, it is crucial to discuss them with your doctor, nurse, pharmacist, or other healthcare provider.

In the event of a suspected overdose, immediately contact your local poison control center or seek emergency medical attention. Be prepared to provide information about the medication taken, the amount, and the time it was taken, as this will aid healthcare professionals in providing appropriate treatment.